OA
FBT icon

Oxbow Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Oxbow Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,735
Closed -$298K – 220
2024
Q3 		$298K Hold
1,735
– – 0.03% 169
2024
Q2 		$267K Sell
1,735
-1,368
-44% -$205K 0.03% 186
2024
Q1 		$477K Sell
3,103
-1,821
-37% -$278K 0.07% 127
2023
Q4 		$778K Sell
4,924
-85
-2% -$12.2K 0.12% 101
2023
Q3 		$733K Sell
5,009
-6,601
-57% -$1.01M 0.12% 95
2023
Q2 		$1.78M Buy
11,610
+370
+3% +$57.7K 0.28% 55
2023
Q1 		$1.74M Sell
11,240
-1,025
-8% -$161K 0.31% 55
2022
Q4 		$1.89M Buy
12,265
+488
+4% +$72K 0.36% 50
2022
Q3 		$1.55M Buy
11,777
+267
+2% +$37.5K 0.24% 68
2022
Q2 		$1.56M Sell
11,510
-185
-2% -$25.5K 0.22% 74
2022
Q1 		$1.74M Hold
11,695
– – 0.18% 82
2021
Q4 		$1.89M Buy
11,695
+220
+2% +$35.6K 0.18% 85
2021
Q3 		$1.91M Buy
11,475
+1,040
+10% +$178K 0.19% 93
2021
Q2 		$1.8M Buy
10,435
+190
+2% +$31.4K 0.19% 99
2021
Q1 		$1.64M Hold
10,245
– – 0.2% 94
2020
Q4 		$1.72M Hold
10,245
– – 0.22% 86
2020
Q3 		$1.61M Hold
10,245
– – 0.2% 92
2020
Q2 		$1.72M Sell
10,245
-425
-4% -$66.7K 0.25% 88
2020
Q1 		$1.4M Sell
10,670
-475
-4% -$67.7K 0.24% 95
2019
Q4 		$1.66M Hold
11,145
– – 0.19% 110
2019
Q3 		$1.38M Sell
11,145
-625
-5% -$83.2K 0.18% 119
2019
Q2 		$1.66M Buy
11,770
+2,200
+23% +$304K 0.2% 111
2019
Q1 		$1.44M Sell
9,570
-190
-2% -$27.3K 0.18% 117
2018
Q4 		$1.21M Sell
9,760
-15,490
-61% -$2.12M 0.16% 128
2018
Q3 		$4M Sell
25,250
-165
-0.6% -$25K 0.48% 61
2018
Q2 		$3.56M Sell
25,415
-1,085
-4% -$149K 0.45% 67
2018
Q1 		$3.52M Buy
26,500
+575
+2% +$78.5K 0.72% 43
2017
Q4 		$3.23M Sell
25,925
-425
-2% -$52.5K 0.6% 50
2017
Q3 		$3.27M Buy
26,350
+200
+0.8% +$23.7K 0.62% 49
2017
Q2 		$2.98M Buy
26,150
+850
+3% +$91.4K 0.53% 62
2017
Q1 		$2.66M Buy
+25,300
New +$2.54M 0.43% 70

Other funds holding FBT

Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Oxbow Advisors's FBT Position: Q4 2024 in Review

Oxbow Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2024, closing a stake of 1,735 shares — an estimated $298K sold.

Oxbow Advisors first reported a position in FBT in Q1 2017 and held it in 31 quarters. The position peaked at $4M in Q3 2018. 256 funds tracked by Wall St. Rank hold FBT as of Q4 2024.

  • Oxbow Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2024 after selling out during the quarter.
  • Oxbow Advisors sold 1,735 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2024, an estimated $298K.
  • Oxbow Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2017 and held it in 31 quarters.
  • Oxbow Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4M in Q3 2018.
  • 256 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2024.

Based on Oxbow Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.